Nanoviricides inc (NNVC) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NNVC Annual Balance Sheets →
This page allows investors to track Nanoviricides inc's balance sheet development across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent3.21
Cash & Short-term Investments3.00
Other Current Assets0.00
Prepaid Expense, Current AS0.16
Total Current Assets3.38
Equipment/Property/Plant Net6.53
Intangible Assets0.31
Other Assets, Noncurrent0.00
Service Agreements0.00
Total Assets10.22
Liabilities
Accounts Payable, Current AC0.13
Accrued Liabilities, Current AC0.03
Other Liabilities, Current0.90
Total Current Liabilities1.07
Total Long-term Debt0.00
Total Liabilities1.07
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock163.99
Retained Earnings / Accumulated Deficit-154.84
Other Equity0.00
Common Stockholder's Equity9.15
Preferred Stockholder's Equity0.00
Total Stockholder's Equity9.15
Liabilities & Stockholder's Equity10.22
4 historic quarters locked

Sign in to unlock the full Nanoviricides inc balance sheet history.

About Nanoviricides Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-061499

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.